FDA Alerts

The FDA approved an intravenous infusion medication to treat symptoms of this rare genetic disease that affects the liver, spleen, lung, and brain.

The US Food and Drug Administration has approved a new treatment for pediatric patients with active psoriatic arthritis.

The US Food and Drug Administration has approved the first systemic treatment for alopecia areata following the publication of results from 2 randomized, placebo-controlled trials.

The FDA has approved the first treatment for eosinophilic esophagitis.

A new treatment option for the management of blood sugar in individuals with type 2 diabetes is approved under FDA priority review designation.

To reduce the amount of tobacco-related disease and death in the United States, the FDA is proposing additional action on flavored cigarettes and cigars.

The US Food and Drug Administration has approved a new medication therapy for the treatment of metastatic and unresectable melanoma.

A generic drug-product combination for the treatment of asthma and COPD was just approved by the US Food and Drug Administration.

The US Food and Drug Administration has approved a treatment option for adults with heart failure.

The US Food and Drug Administration has approved a second vaccine for the prevention of COVID-19.